Systemic Treatment of Breast Cancer. 1st Central-Eastern European Professional Consensus Statement on Breast Cancer

Gábor Rubovszky(National Institute of Oncology), Judit Kocsis(Bács-Kiskun Megyei Kórház), Boer Katalin(Szent János Kórház), Chilingirova Nataliya(Medical University Pleven), Dank Magdolna(Semmelweis University), Kahán Zsuzsanna(University of Szeged), Kaidarova Dilyara(Kazakh Institute of Oncology and Radiology), Erika Kövér(University of Pecs), Vertakova Krakovska Bibiana(Comenius University Bratislava), Mahr Karoly, Piko Bela(Békés Megyei Központi Kórház), Boožović-Spasojević Ivana(Oncology Institute of Vojvodina), Horvath Zsolt(Bács-Kiskun Megyei Kórház), Central-Eastern European Academy Of Oncology (CEEAO) International Professional Panel
Zenodo (CERN European Organization for Nuclear Research)
July 11, 2022
Cited by 0Open Access
Full Text

Abstract

Abstract. This text is based on the recommendations accepted by the 4th Hungarian Consensus Conference on Breast Cancer, modified based on the international consultation and conference within the frames of the Central-Eastern European Academy of Oncology. The professional guideline primarily reflects the resolutions and recommendations of the current ESMO, NCCN and ABC5, as well as that of the St. Gallen Consensus Conference statements. The recommendations cover classical prognostic factors and certain multigene tests, which play an important role in therapeutic decision-making. From a didactic point of view, the text first addresses early and then locally advanced breast cancer, followed by locoregionally recurrent and metastatic breast cancer. Within these, we discuss each group according to the available therapeutic options. At the end of the recommendations, we summarize the criteria for treatment in certain rare clinical situations.


Related Papers

No related papers found

Powered by citation graph analysis